Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04752059
Title Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases (TUXEDO-1)
Acronym TUXEDO-1
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Medical University of Vienna
Indications
Therapies
Age Groups: adult
Covered Countries AUT


No variant requirements are available.